Dermatophyte infections.
The newer antifungal agents, clotrimazole, miconazole and haloprogin are considered for their efficacy and acceptability, and are compared with other topical agents used for the treatment of dermatophyte infections of the skin.
D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003022:Clotrimazole / Q000627:therapeutic use; D003881:Dermatomycoses / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D008825:Miconazole / Q000627:therapeutic use; D010647:Phenyl Ethers / Q000627:therapeutic use; D014047:Tolnaftate / Q000627:therapeutic use
D000935:Antifungal Agents; D010647:Phenyl Ethers; D014047:Tolnaftate; D006118:Griseofulvin; D008825:Miconazole; D003022:Clotrimazole